Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06626321 · ClinicalTrials.gov registry record · NA
Behavioral Economics to Improve Flu Vaccination Using EHR Nudges Replication
A NA study of Behavior, Health and FLU, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 26,248
- Enrollment target
- 1
- Study location
NCT06626321: Completed NA study of Behavior, Health and FLU, sponsored by University of Pennsylvania.
NCT06626321 is a NA study of Behavior, Health and FLU that has completed, run by University of Pennsylvania. The registered enrollment target is 26,248 participants, above the 14,479-participant average among 20 other Behavior, Health trials with a reported enrollment target (81% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06626321, a NA study of Behavior, Health and FLU, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 26,248 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a 6-month, cluster randomized, pragmatic replication trial to evaluate the effectiveness of personalized nudges to clinicians and patients, relative to a control, to increase flu vaccination rates among older adults in accordance with CDC guidelines. This will include clinician and patient level nudge interventions, with additional, intensified nudge interventions for patients identified as high risk for not receiving a flu vaccine. Among the intervention clinics, patients will receive pre-visit text message reminders about the flu vaccine, and clinicians will receive a default pended order in the visit encounter in the EHR, along with monthly peer comparison feedback about their flu vaccine completion rate. Patients identified as high risk for noncompletion will be individually randomized to receive an additional bidirectional text message nudge or the standard text messaging
Primary Outcome
The primary outcome is flu vaccination completion during the first eligible primary care visit.
Conditions Studied
Interventions
- BEHAVIORAL Pre-visit patient text messaging
- BEHAVIORAL Default pended order
- BEHAVIORAL Monthly peer comparison feedback
- BEHAVIORAL High risk bidirectional pre-visit text messaging
Study Locations (1)
Pennsylvania
- Lancaster General Health - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,248 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2025-05-28 |
| Phase | NA |
What the finished NCT06626321 record still lists
NCT06626321 is an interventional study that assigns participants to a tested intervention. Its 26,248 participants enrollment target places it among the larger protocols in the corpus, above the 14,479-participant average among 20 other Behavior, Health trials with a reported enrollment target (81% higher).
The record links to 3 conditions, with Behavior, Health appearing as the primary indexed condition, and to 4 interventions - of which Pre-visit patient text messaging is the first listed.
NCT06626321 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06626321 about?
NCT06626321 is a clinical study titled "Behavioral Economics to Improve Flu Vaccination Using EHR Nudges Replication". This study will be a 6-month, cluster randomized, pragmatic replication trial to evaluate the effectiveness of personalized nudges to clinicians and patients, relative to a control, to increase flu vaccination rates among older adults in accordance with CDC guidelines. This will include clinician an...
What is the current status of trial NCT06626321?
This trial is currently completed. It is a NA study. The enrollment target is 26,248 participants. The study started on 2024-10-21. Estimated completion is 2025-05-28.
What conditions does trial NCT06626321 study?
This clinical trial studies the following conditions: Behavior, Health, FLU, Flu Vaccination.
What interventions are being tested in trial NCT06626321?
The interventions under investigation include: Pre-visit patient text messaging (BEHAVIORAL), Default pended order (BEHAVIORAL), Monthly peer comparison feedback (BEHAVIORAL), High risk bidirectional pre-visit text messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06626321?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06626321 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior, Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06626321's enrollment target sits among peer trials
26,248 3rd of 20 higher than 18 of 20 other Behavior, Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Behavior, Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Fit With Us Study
RECRUITING · NA
-
Parent-Child Memory Study: Improving Future Thinking Among Mothers
RECRUITING · NA
-
Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
RECRUITING · NA
-
Game-based Pediatric Diabetes Education
RECRUITING · NA
-
Personalized Health Self-Management Training for Colorectal Cancer Survivors
RECRUITING · NA
-
Improving Congenital Heart Disease Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI